Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MP vs MRNA✓SelectedUSD · MRNAMP vs MRNA performance historyLatest closeAs of+3.13%11/18
Stock and ETF performance explorer

MP vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-38.6%
MRNA return
+703.6%
Excess return
-742.1%
Maximum drawdown
-53.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+3.1%-4.8%+8.0%+3.3%
7D-2.1%-20.9%+18.7%-1.3%
30D-7.7%-13.3%+5.6%-7.3%
3M-36.6%+212.6%-249.1%-39.9%
6M-36.6%+309.0%-345.6%-44.4%
YTD-28.8%+567.3%-596.2%-44.9%
1Y-38.6%+689.7%-728.2%-55.8%
All-38.6%+703.6%-742.1%-55.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling